Tuesday, August 1, 2017

ChineseInvestors.com, Inc. (CIIX) Getting Some Skin in the Game

- Entering $30+ billion Chinese skin care market

- First and only CBD-based products to market

- Expects to capture huge share of new skin care products category


Any dispute over the efficacy of medical cannabis is settled science. Recent prestigious clinical studies have provided conclusive evidence that medical cannabinoids are effective medicine for a variety of diseases and ailments (http://dtn.fm/51coN). Cannabidiol (CBD) has been scientifically shown to be effective in the treatment of certain epilepsies, pain, inflammation and nausea, as well as providing relief from hangover, anxiety and stress.

It comes as little surprise then that cannabis may well possess skin healing properties. Cannabis is a known anti-inflammatory containing antioxidant and anti-aging elements. Hemp seed oil contains omega-3 and omega-6 fatty acids. These essential fatty acids can enhance complexion by improving the skin’s texture and softness. They keep skin cells moist by reducing the amount of water lost through the epidermis, and they also increase production of collagen, a protein that makes up connective tissue and is a structural building block of firm, healthy skin. The human endocannabinoid system utilizes multiple cannabinoid receptors, and a large number of these are actually found in the skin.

In spite of vast anecdotal evidence, hard science has not yet settled on the positive effects of CBD skin care. However, it took decades and overcoming wrong-headed preconceptions to scientifically prove the medical efficacy of CBD in multiple maladies. It should easily follow that there are underlying benefits of topical cannabis-based skin care products.

When looking for opportunity in this new arena, look to China, the second-largest consumer of skin care products in the world, generating nearly $30 billion in annual retail sales. The recent article “Investment Options in the Multi-Billion Dollar Medical Marijuana Industry” (http://dtn.fm/w4Mhs) highlighted ChineseInvestors.com (OTCQB: CIIX) entering the multi-billion Chinese skin care industry with the introduction of a new line of cannabidiol-based skin care products. The company has filed a record of its first line of hemp-infused skin care products with the China Food and Drug Administration (http://dtn.fm/eMv58) and expects to launch in the next couple months.

As the company stated in its press release, “Although ancient Chinese recognized the medicinal properties of the cannabis plant, CBD extract appears to be largely unrecognized in China today for its benefits, including but not limited to, its potential benefits to the largest visible human organ, the skin.”

When one considers how prevalent skin conditions are, it becomes clear that a safe, effective new treatment is likely to be embraced by a significant portion of the population. Understandably, the market potential is enormous. Not only is the market potential huge, the company anticipates capturing “100% of China’s market share in this novel skin care products category,” since, to its knowledge, no other manufacturers have entered the cannabis skin care product market in China.

Given the immense opportunity in CBD-based skin care and the multiple markets and products that ChineseInvestors.com is pursuing, it very well may be time to get some skin in the game.

For more information, visit the company’s website at www.ChineseInvestors.com

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

No comments: